Vascular Factors and Markers of Inflammation in Offspring With a Parental History of Late-Onset Alzheimer Disease

被引:65
|
作者
van Exel, Eric [1 ]
Eikelenboom, Piet [1 ,4 ]
Comijs, Hannie [1 ]
Froelich, Marijke [5 ]
Smit, Johannes H. [1 ]
Stek, Max L. [1 ]
Scheltens, Philip [2 ]
Eefsting, Jan E. [3 ]
Westendorp, Rudi G. J. [6 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Nursing Home Med, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands
[5] Leiden Univ, Med Ctr, Dept Clin Chem, Leiden, Netherlands
[6] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands
关键词
COGNITIVE FUNCTION; DIABETES-MELLITUS; CONTROLLED-TRIAL; WHOLE-BLOOD; FOLIC-ACID; RISK; DEMENTIA; CAREGIVERS; DECLINE; AGE;
D O I
10.1001/archgenpsychiatry.2009.146
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: Alzheimer disease (AD) is a complex disorder with a strong heritable component. Amyloid pathology, vascular factors, and inflammation are postulated to be involved in its pathogenesis, but causality has not been established unequivocally. Objective: To identify heritable traits in middle age that contribute to AD. Design: We used a proven family design, comparing middle-aged offspring with and without a parental history of AD. In such a design, the offspring under study are enriched for risk factors of AD but do not yet have the disease. Setting: The Netherlands. Participants: Two hundred six offspring of 92 families with a parental history of late-onset AD and 200 offspring of 97 families without a parental history of AD. Main Outcome Measures: The APOE epsilon 4 genotype, vascular factors, production capacity of pro- and anti-inflammatory cytokines upon stimulation with lipopolysaccharide, and circulating markers of inflammation. All outcome measures were assessed in the offspring only and not in the parental generation. Results: More offspring with a parental history of AD carried APOE e4 than those without a parental history of the disease (47% vs 21%, P<.001). Those with a parental history of AD also had higher systolic blood pressures (P=.006), higher diastolic blood pressures (P<.001), and lower ankle brachial indices (P=.005) when compared with offspring without a family history of dementia. Production capacity of pro- inflammatory cytokines in offspring with a parental history of AD was also different, with higher levels of IL-1 beta (interleukin 1 beta) (P<.001), IL-1 beta to IL-1ra ratio (P<.001), tumor necrosis factor alpha (P=.008), IL- 6 (P=.04), and interferon gamma (P=.01). All of these positive associations were independent of APOE epsilon 4 genotype. Conclusions: Hypertension and the expression of an innate pro- inflammatory cytokine profile in middle age are early risk factors of AD in old age. For the offspring of affected families, it provides clues for screening and preventive strategies, of which blood pressure control can be implemented directly.
引用
收藏
页码:1263 / 1270
页数:8
相关论文
共 50 条
  • [21] Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease
    Acha, Blanca
    Corroza, Jon
    de Gordoa, Javier Sanchez-Ruiz
    Cabello, Carolina
    Robles, Maitane
    Mendez-Lopez, Ivan
    Macias, Monica
    Zueco, Sara
    Roldan, Miren
    Urdanoz-Casado, Amaya
    Jerico, Ivonne
    Erro, Maria Elena
    Alcolea, Daniel
    Lleo, Alberto
    Blanco-Luquin, Idoia
    Mendioroz, Maite
    NEUROLOGY, 2023, 101 (23) : E2434 - E2447
  • [22] Investigation of MAPT Subhaplotypes as Risk Factors for Late-Onset Alzheimer's Disease
    Allen, Mariet
    Kachadoorian, Michaela
    Quicksall, Zachary
    Zou, Fanggeng
    Chai, High Seng
    Younkin, Curtis
    Crook, Julia
    Pankratz, Vernon
    Carrasquillo, Minerva
    Krishnan, Siddharth
    Thuy Nguyen
    Ma, Li
    Malphrus, Kimberly
    Lincoln, Sarah
    Bisceglio, Gina
    Kolbert, Christopher
    Jen, Jin
    Petersen, Ronald
    Graff-Radford, Neill
    Dickson, Dennis
    Younkin, Steven
    Taner, Nilufer
    NEUROLOGY, 2013, 80
  • [23] In vivo validation of late-onset Alzheimer's disease genetic risk factors
    Sasner, Michael
    Preuss, Christoph
    Pandey, Ravi S.
    Uyar, Asli
    Garceau, Dylan
    Kotredes, Kevin P.
    Williams, Harriet
    Oblak, Adrian L.
    Lin, Peter Bor-Chian
    Perkins, Bridget
    Soni, Disha
    Ingraham, Cindy
    Lee-Gosselin, Audrey
    Lamb, Bruce T.
    Howell, Gareth R.
    Carter, Gregory W.
    ALZHEIMERS & DEMENTIA, 2024, 20 (07) : 4970 - 4984
  • [24] THE NATURAL-HISTORY OF LATE-ONSET EPILEPSY SECONDARY TO VASCULAR-DISEASE
    FISH, DR
    MILLER, DH
    ROBERTS, RC
    BLACKIE, JD
    GILLIATT, RW
    ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 (06): : 524 - 526
  • [25] Identification of novel genes in late-onset Alzheimer disease
    Pericak-Vance, MA
    Duke, JB
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S11 - S11
  • [26] Late-onset autosomal dominant Alzheimer's disease
    Hancock, P.
    Larner, A. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 187 - 188
  • [27] Deciphering the mechanism underlying late-onset Alzheimer disease
    Dimitrije Krstic
    Irene Knuesel
    Nature Reviews Neurology, 2013, 9 : 25 - 34
  • [28] Deciphering the mechanism underlying late-onset Alzheimer disease
    Krstic, Dimitrije
    Knuesel, Irene
    NATURE REVIEWS NEUROLOGY, 2013, 9 (01) : 25 - 34
  • [29] Etiology and Pathogenesis of Late-Onset Alzheimer's Disease
    Balin, Brian J.
    Hudson, Alan P.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2014, 14 (03)
  • [30] LINKING Aβ AND TAU IN LATE-ONSET ALZHEIMER'S DISEASE
    Small, S. A.
    GERONTOLOGIST, 2009, 49 : 143 - 143